El primer episodio estará dedicado a uno de los grandes campos de la innovación a nivel mundial, uno de los que más dudas y controversias genera y que, en tiempos de pandemia y de vacunas, está de plena actualidad. Hablaremos de las patentes biotecnológicas con la participación de Nicolás Vincent Ruiz, Global Intellectual Property Head de ESTEVE, junto a Patricia Ramos, directora Área Patentes PONS IP y Ana Herrera Arroyo, responsable de Biotecnología del Área Patentes PONS IP a la que también hemos entrevistado. Para la firma invitada, contaremos con la participación de José Antonio Gil Celedonio, director de la Oficina Española de Patentes y Marcas (OEPM).
IP newsthat
may interest you
An analysis by PONS IP’s Trademark Department identifies the key implications of the reform for companies’ portfolios, protection strategies and business operations in China China is preparing a significant overhaul of its trademark system. The new Trademark Law, which will...
By Ana Herrera Arroyo, Director of Patents, Technology Development and Innovation, PONS IP In the world of technological innovation, there is a widely held belief that if a company obtains a patent for its invention, it automatically has the right...
The 21st edition in Madrid and the launch of the first international edition in Barcelona mark a new chapter for a programme that has already trained more than 400 professionals and is expanding its global reach this year through a...
NEWSLETTER
All the IP News
in your e-mail
Find out all the latest information on IP to boost the development of your organisation.
Subscribe to our bimonthly newsletter
International Awards
and Recognitions


